These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23529168)

  • 1. Cathepsin K knockout alleviates pressure overload-induced cardiac hypertrophy.
    Hua Y; Xu X; Shi GP; Chicco AJ; Ren J; Nair S
    Hypertension; 2013 Jun; 61(6):1184-92. PubMed ID: 23529168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathepsin K knockout mitigates high-fat diet-induced cardiac hypertrophy and contractile dysfunction.
    Hua Y; Zhang Y; Dolence J; Shi GP; Ren J; Nair S
    Diabetes; 2013 Feb; 62(2):498-509. PubMed ID: 23069627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin K knockout alleviates aging-induced cardiac dysfunction.
    Hua Y; Robinson TJ; Cao Y; Shi GP; Ren J; Nair S
    Aging Cell; 2015 Jun; 14(3):345-51. PubMed ID: 25692548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCN2/CTGF attenuates myocardial hypertrophy and cardiac dysfunction upon chronic pressure-overload.
    Gravning J; Ahmed MS; von Lueder TG; Edvardsen T; Attramadal H
    Int J Cardiol; 2013 Oct; 168(3):2049-56. PubMed ID: 23452880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preserved heart function after left ventricular pressure overload in adult mice subjected to neonatal cardiac hypoplasia.
    Heinecke K; Heuser A; Blaschke F; Jux C; Thierfelder L; Drenckhahn JD
    J Dev Orig Health Dis; 2018 Feb; 9(1):112-124. PubMed ID: 28737122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periostin is a novel factor in cardiac remodeling after experimental and clinical unloading of the failing heart.
    Stansfield WE; Andersen NM; Tang RH; Selzman CH
    Ann Thorac Surg; 2009 Dec; 88(6):1916-21. PubMed ID: 19932262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZNF307 (Zinc Finger Protein 307) Acts as a Negative Regulator of Pressure Overload-Induced Cardiac Hypertrophy.
    Yu CJ; Liang C; Li YX; Hu QQ; Zheng WW; Niu N; Yang X; Wang ZR; Yu XD; Zhang BL; Song BL; Zhang ZR
    Hypertension; 2017 Apr; 69(4):615-624. PubMed ID: 28223477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial Leptin Receptor Deletion Promotes Cardiac Autophagy and Angiogenesis Following Pressure Overload by Suppressing Akt/mTOR Signaling.
    Gogiraju R; Hubert A; Fahrer J; Straub BK; Brandt M; Wenzel P; Münzel T; Konstantinides S; Hasenfuss G; Schäfer K
    Circ Heart Fail; 2019 Jan; 12(1):e005622. PubMed ID: 30621510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth Arrest-Specific 6 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy.
    Zhao YF; Xu DC; Zhu GF; Zhu MY; Tang K; Li WM; Xu YW
    Hypertension; 2016 Jan; 67(1):118-29. PubMed ID: 26573712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SENP1 Protects Against Pressure Overload-Induced Cardiac Remodeling and Dysfunction Via Inhibiting STAT3 Signaling.
    Yang D; Fan D; Guo Z; Liu FY; Wang MY; An P; Yang Z; Tang QZ
    J Am Heart Assoc; 2022 Nov; 11(22):e027004. PubMed ID: 36370010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy.
    Jiang DS; Bian ZY; Zhang Y; Zhang SM; Liu Y; Zhang R; Chen Y; Yang Q; Zhang XD; Fan GC; Li H
    Hypertension; 2013 Jun; 61(6):1193-202. PubMed ID: 23589561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of heart failure by minimally invasive aortic constriction in mice: reduced peroxisome proliferator-activated receptor γ coactivator levels and mitochondrial dysfunction.
    Faerber G; Barreto-Perreia F; Schoepe M; Gilsbach R; Schrepper A; Schwarzer M; Mohr FW; Hein L; Doenst T
    J Thorac Cardiovasc Surg; 2011 Feb; 141(2):492-500, 500.e1. PubMed ID: 20447656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
    Zhou N; Ma B; Stoll S; Hays TT; Qiu H
    Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
    Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth/differentiation factor 1 alleviates pressure overload-induced cardiac hypertrophy and dysfunction.
    Zhang Y; Zhang XF; Gao L; Liu Y; Jiang DS; Chen K; Yang Q; Fan GC; Zhang XD; Huang C
    Biochim Biophys Acta; 2014 Feb; 1842(2):232-44. PubMed ID: 24275554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
    Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
    J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of β3-adrenergic receptor relieves pressure overload-induced cardiac hypertrophy and heart failure via enhancing innate immune response.
    Wei X; Zhang A; Yang W; Fang Y
    Biomed Pharmacother; 2021 Nov; 143():112194. PubMed ID: 34563949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2.
    Wang H; Lai Y; Mathis BJ; Wang W; Li S; Qu C; Li B; Shao L; Song H; Janicki JS; Sun SC; Wang XL; Tang D; Cui T
    J Mol Cell Cardiol; 2015 Jul; 84():143-53. PubMed ID: 25935309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-1 deficiency resists cardiac hypertrophy and myocardial contractile dysfunction: role of microRNA-1 and microRNA-133a.
    Hua Y; Zhang Y; Ren J
    J Cell Mol Med; 2012 Jan; 16(1):83-95. PubMed ID: 21418519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT/GSK3beta signaling.
    Tang Q; Cai J; Shen D; Bian Z; Yan L; Wang YX; Lan J; Zhuang GQ; Ma WZ; Wang W
    J Mol Med (Berl); 2009 Mar; 87(3):249-60. PubMed ID: 19096818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.